SavedAdd your journal

Journals / Harran Üniversitesi Tıp Fakültesi Dergisi / 2016 / Cilt: 13 - Sayı: 1

Eosinophilic Granulomatosis With Polyangiitis (Churg Strauss Syndrome): Case Report

Polianjitisle Seyreden Eozinofilik Granülomatozis (Churg Strauss Sendromu): Olgu Sunumu

Hakan TANRIVERDİ
Fırat UYGUR
Bülent ALTINSOY
Fatma ERBOY
Ömer YAZGAN
Figen ATALAY
Pages
84–87
Publication Date
2016-04-28
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Here, we present a case of EGPAunrelated to LTRAs.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Eosinophilic granulomatosis with polyangiitis (EGPA) is a systemic necrotizing vasculitis characterized by tissue and blood eosinophilia.
📊
Key Findings & Data:Several drugs including leukotriene receptor antagonists (LTRAs) are suspected to trigger EGPAdevelopment.
💡
Conclusion & Impact:Here, we present a case of EGPAunrelated to LTRAs.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Eozinofili · lökotrien reseptör antagonisti · eozinofilik granülamatöz

Abstract

Eosinophilic granulomatosis with polyangiitis (EGPA) is a systemic necrotizing vasculitis characterized by tissue and blood eosinophilia. Several drugs including leukotriene receptor antagonists (LTRAs) are suspected to trigger EGPAdevelopment. Here, we present a case of EGPAunrelated to LTRAs.

Özet

Polianjitisle birlikte seyreden eozinofilik granülomatozis (Churg Strauss sendromu), nadir, sıklıkla solunum sistemini tutan ve özellikle küçük ve orta çaplı damarları etkileyen, astım ve doku eozinofilisi ile karakterize, sistemik nekrotizan bir vaskülittir. Lökotrien antagonistlerini de içeren pek çok ilacın bu hastalığın gelişiminde rolü olduğundan şüphelenilmektedir. Biz de klinik ve radyolojik bulgularla tanı alan ve lökotrien reseptör antagonistleri ile ilişkili olmadığını düşündüğümüz bir olguyu sunmak istedik.

🔖

Cite This Article

TANRIVERDİ, H., UYGUR, F., ALTINSOY, B., ERBOY, F., YAZGAN, Ö., ATALAY, F. (2016). Eosinophilic Granulomatosis With Polyangiitis (Churg Strauss Syndrome): Case Report. Harran Üniversitesi Tıp Fakültesi Dergisi, Cilt: 13 - Sayı: 1, 84–87. https://ajindex.com/articles/104259

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Groh M, Pagnoux C, Baldini C, Bel E, Bottero P, Cottin V et al. Eosinophilic granulomatosis with polyangiitis (Churg–Strauss) (EGPA) Consensus Task Force recommendations for evaluation and management. Eur J Intern Med. 2015;26 (7):545-53. http://dx.doi.org/10.1016/j.ejim.2015.04.022 2.Samson M, Puéchal X, Devilliers H, Ribi C, Cohen P, Stern M et al. Long-term outcomes of 118 patients with eosinophilic granulomatosis with polyangiitis (ChurgStrauss syndrome) enrolled in two prospective trials. J Autoimmun 2013;43:60-9. 3.Ramentol-Sintas M, Martínez-Valle F, Solans-Laqué R. Churg–Strauss Syndrome: An evolving paradigm. Autoimmun Rev 2012;12(2):235–40. Masi AT 1 4., Hunder GG, Lie JT, Michel BA, Bloch DA, Arend WP, et al. The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum. 1990;33(8):1094-100. 5.Yıldız F, Zorludemir S, Erken E. Montelukast ilişkili Churg Strauss sendromu: Üç olgu. Cukurova Med J 2014;39(2):347-52 6.Bibby S, Healy B, Steele R, Kumareswaran K, Nelson H, Beasley R. Association between leukotriene receptor antagonist therapy and Churg–Strauss syndrome: an analysis of the FDA AERS database. Thorax 2010;65(2):132–8 7.Hauser T, Mahr A, Metzler C, Coste J, Sommerstein R, Gross WL, e t a l. The l eucotri ene r e c eptor antagonistmontelukast and the risk of Churg–Strauss Sy n d r ome: a c a s e - c r o ss o v e r st u d y. Th o r a x 2008;63(8):677–82. 8.Abril A, Calamia KT, Cohen MD. The Churg Strauss syndrome (Allergic granulomatous angiitis): Review and update. Semin Arthritis Rheum 2003;33:106-14.